The ICH (International , FL, U.S.A., emphasized the need for research into the suitability of various methods for the detection of effects on fertility in males. The current project was undertaken to compare the efficiency of methods by evaluating reports in the open literature. The results of the examination of 117 substances or substance classes support the view that histopathology and organ weight analysis provide the best general-purpose means of detecting substances with the potential to affect male fertility. Examinations at up to 4 weeks of treatment appear to be as effective as examinations conducted at later times. Mating with females for detection of effects unrelated to interference with sperm production appears to provide an optimal combination because adding other methodologies does not materially improve the detection rate. As to the timing of the mating trial, a 2-week premating period is as efficient as mating at 4 weeks and apparently more efficient than mating after prolonged premating treatment. of male fertility following treatment for 60 days (9 weeks) or more. Over the years, experience with the various designs for fertility tests, repeat-dose toxicity studies, and dominant-lethal assays generated doubt as to the sensitivity of mating or the necessity for such a long time of treatment prior to mating (Palmer, 1986). The first consideration of this doubt by agencies was during the discussions of the ICH Guideline on Detection of Toxicity to Reproduction for Medicinal Products (Bass et al., 1991), which placed more emphasis on direct methods for examination of effects on spermatogenesis and, in earlier drafts, recommended a shorter, 2-week, premating treatment period. Another example is OECD Guideline 421 for Industrial Chemicals, which requires a 2-week premating treatment. So far, this change in direction has not been incorporated into other guidelines.The ICH Guideline for Detection of Toxicity to Reproduction for Medicinal Products, adopted at the Second International Conference on Harmonization (Orlando, FL, U.S.A., 1993), suggested use of data from repeat-dose toxicity studies, additional sperm analysis, and a 4-week premating treatment for males. However, these can be considered interim measures as the guideline also recognized the need for research into the suitability of various methods for the detection of effects on male reproduction. The current project was undertaken to compare the relative efficiency of various methods by evaluating reports in the open literature. METHODSArticles were identified by way of a database search (DIMDI, Cologne) for substances that had been reported to affect males with respect to fertility, spermatogenesis, and mating behavior. Of some 150 substances (or groups of substances) identified, 117 were included in the evaluation on the basis of the amount of information available. Substances were included even with scarce animal data when effects had been reported in men. Additional information on some compounds came from agency files.Single endpoints that...
No abstract
Tests for detection of neurobehavioral changes in the offspring have been a regulatory requirement in developmental toxicity testing of drugs for almost 20 years. Keeping their purpose of hazard identification and risk assessment for humans in mind, investigators and agency reviewers have become deeply ingrained with some stereotyped behaviors with respect to such relevant issues as choice of animal species and data evaluation. Other problematic areas of study design and conduct, selection of litter representatives for testing, what methods to combine in a testing battery, and statistical treatment of results and their interpretation, will need more research and discussion in the future.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.